InvestmentPitch Media Video Discusses FSD Pharma's Cost Award of $2.81 Million from Dr. Raza Bokhari in an Arbitration Settlement

Stock Information for FSD Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About FSD Pharma Inc.

InvestmentPitch Media Video Discusses FSD Pharma's Continued Development of its Exciting New Rapid Detox Drink UNBUZZD(TM), with Video Comments from Kevin Harrington
FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated
FSD Pharma Announces Analyst Coverage Initiated by Singular Research
FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)
FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 - 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023
InvestmentPitch Media Video Features FSD Pharma's Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
FSD Pharma Signs Definitive Agreement to Launch UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.